Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070393 · ClinicalTrials.gov registry record · Early Phase 1
Breast-Sparing Proton Therapy for Hodgkin's Disease
A Early Phase 1 study, sponsored by Indiana University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT02070393: Clinical Trial Early Phase 1 study, sponsored by Indiana University.
NCT02070393 is a Early Phase 1 study that was terminated before completion, run by Indiana University. The registered enrollment target is 3 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02070393, a Early Phase 1 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to drastically reduce unnecessary breast dose in young females with Hodgkin's Disease who require radiation therapy.
Primary Outcome
Dose-volume histogram data from both the delivered proton plan and the accompanying photon plan for target volumes and normal tissues, including: • Breast, heart, lung, thyroid, parotid glands , esophagus, spinal cord, \*liver, \*kidneys,
Interventions
- RADIATION Proton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-02 |
| Phase | Early Phase 1 |
Why NCT02070393 stopped before completion
NCT02070393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Proton is the first listed.
NCT02070393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02070393 about?
NCT02070393 is a clinical study titled "Breast-Sparing Proton Therapy for Hodgkin's Disease". The purpose of this study is to drastically reduce unnecessary breast dose in young females with Hodgkin's Disease who require radiation therapy.
What is the current status of trial NCT02070393?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2011-09. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02070393?
The interventions under investigation include: Proton (RADIATION).
Who is sponsoring clinical trial NCT02070393?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02070393's enrollment target sits among peer trials
3 1948th of 2000 higher than 28 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia